• Markets
    • icon
  • Companies
LBT · ASX

LBT Innovations Limited (ASX:LBT)

AU$0.018

 0.002 (12.5%)
ASX:Live
04/12/2023 03:34:24 PM
Volume Spike (Realtime) Near Resistance (Realtime) Hammer Bearish HALO Ords GROWTH AUS +3
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

LBT Overview

LBT Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About LBT

Website

LBT Innovations Limited

Telephone

N/A

Address

Description

LBT Innovations Ltd. is an Australian developer of clinical and diagnostic technology, which has emerged as a groundbreaking designer of advanced automated solutions for the preparation and analysis of microbiology culture specimens, with significant benefits for busy clinical laboratories. The firm operates its business through research and development segments. The company was founded by Lusia Halina Guthrie, Douglas Peter LeMessurier and Paul Andrew Mariani in 2004 and is headquartered in Adelaide, Australia.

LBT Price Chart

Key Stats

Market Cap

AU$15.03M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.06

Trade Value (12mth)

AU$2,322.00

1 week

100%

1 month

300%

YTD

-59.18%

1 year

-56.87%

All time high

0.7595

Key Fundamentals

EPS 3 yr Growth

100.000%

EBITDA Margin

-180.30%

Operating Cashflow

-$1m

Free Cash Flow Return

-10.50%

ROIC

-169.70%

Interest Coverage

-8.20

Quick Ratio

0.80

Other Data

Shares on Issue (Fully Dilluted)

473m

HALO Sector

Healthcare

Next Company Report Date

29-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

LBT Announcements

Latest Announcements

Date Announcements

31 October 22

Application for quotation of securities - LBT

×

Application for quotation of securities - LBT

31 October 22

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

31 October 19

Presentation at Australia Biotech Invest & Partnering 2019

×

Presentation at Australia Biotech Invest & Partnering 2019

31 July 23

Application for quotation of securities - LBT

×

Application for quotation of securities - LBT

31 August 23

Preliminary Annual Financial Report & Appendix 4E

×

Preliminary Annual Financial Report & Appendix 4E

31 August 22

New Data Published on APAS Technology

×

New Data Published on APAS Technology

30 September 19

Annual Report to shareholders

×

Annual Report to shareholders

30 November 23

APAS Presented at Australian Pharmaceutical Conference

×

APAS Presented at Australian Pharmaceutical Conference

30 November 06

Results of Annual General Meeting

×

Results of Annual General Meeting

30 March 23

Director Retirement & Appendix 3Z

×

Director Retirement & Appendix 3Z

30 December 21

Application for quotation of securities - LBT

×

Application for quotation of securities - LBT

30 December 21

Notification regarding unquoted securities - LBT

×

Notification regarding unquoted securities - LBT

30 December 21

Notice under Section 708A - Cleansing Notice

×

Notice under Section 708A - Cleansing Notice

30 December 21

Appendix 3Y - Joanne Moss

×

Appendix 3Y - Joanne Moss

30 December 21

Appendix 3Y - Brian O'Dwyer

×

Appendix 3Y - Brian O'Dwyer

30 December 21

Appendix 3Y - Damian Lismore

×

Appendix 3Y - Damian Lismore

30 December 21

Appendix 3Y - Simon Arkell

×

Appendix 3Y - Simon Arkell

30 April 20

Presentation at NWR Virtual Small Cap Conference

×

Presentation at NWR Virtual Small Cap Conference

30 April 19

Business Update Presentation

×

Business Update Presentation

29 September 23

Corporate Governance Statement

×

Corporate Governance Statement

29 September 23

Appendix 4G

×

Appendix 4G

29 September 23

Annual Report

×

Annual Report

29 September 21

Annual Report to shareholders

×

Annual Report to shareholders

29 September 17

Annual Report to shareholders

×

Annual Report to shareholders

29 September 11

Annual Report to shareholders

×

Annual Report to shareholders

29 September 06

2006 Annual Report

×

2006 Annual Report

29 November 23

Chair's Address to Shareholders

×

Chair's Address to Shareholders

29 November 23

CEO Presentation

×

CEO Presentation

LBT Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.03 -0.02 -0.05 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.03 -0.02 -0.05 Lock Lock Lock
     Growth % Lock Lock Lock Lock -5.9 13.8 -119.3 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.02 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 16.3 -5.4 -20.8 Lock Lock Lock
     Yield % Lock Lock Lock Lock -12.8 -21.1 -14.2 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.09 0.07 -0.00 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.03 0.02 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 8.5 -53.4 -101.3 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 287 305 471 Lock Lock Lock
Basic m Lock Lock Lock Lock 287 305 471 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 1 2 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -3.4 89.5 0.2 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 1 2 2 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -6 -6 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -9.2 -10.4 10.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -505.2 -294.3 -263.8 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 605 394 364 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -4 -5 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -14.1 -30.6 22.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -338.9 -233.5 -180.3 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 2 3 3 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -6 -8 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -7.6 -27.3 9.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -552.5 -371.2 -334.9 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -6 -8 -21 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -2 -2 2 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -7 -7 -23 Lock Lock Lock
     Growth % Lock Lock Lock Lock -28.8 8.5 -239.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -646.5 -312.1 -1,056.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -3 -5 -1 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 1 1 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -2 -1 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 7 -1 1 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -3 -5 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -47.2 -80.3 72.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2.5 -2.4 -0.7 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 10 3 2 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 36 32 7 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 4 3 2 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -5 1 1 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 11 10 7 Lock Lock Lock
Equity $m Lock Lock Lock Lock 25 21 0 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 29 24 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 5.8 -14.5 -91.5 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -20.3 -21.1 -305.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -29.2 -31.1 21,451.4 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -21.5 -28.5 -49.4 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -26.1 -25.0 -169.7 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -9.6 -18.6 -10.5 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -32.8 -47.8 -8.2 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.2 -0.3 -0.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -19.1 7.0 -1,301.9 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 4.5 2.4 1.2 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 4.5 2.1 0.8 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 83.1 39.9 41.7 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -103.4 -173.3 -33.4 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.8 0.8 0.9 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A 17.1 6.3 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.1 0.5 3.3 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 125.4 38.7 31.9 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.3 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.3 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -515.3 -385.6 -979.5 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -16.2 -26.0 -283.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -20.3 -21.1 -305.6 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.4 1.5 -70.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -29.2 -31.1 21,451.4 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -29.2 -31.1 21,451.4 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A 21.3 58.1 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 453.2 442.7 388.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 453.2 464.0 446.8 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 56.0 43.4 33.2 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 397.2 420.6 413.7 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

LBT Shortsell

Frequently Asked Questions

The current share price of LBT Innovations Limited (LBT:ASX) is AU$0.018.
The 52-week high share price for LBT Innovations Limited (LBT:ASX) is AU$0.06.
The 52-week low share price for LBT Innovations Limited (LBT:ASX)? is AU$0.00.
LBT Innovations Limited (LBT:ASX) does not pay a dividend.
LBT Innovations Limited (LBT:ASX) does not pay a dividend.
LBT Innovations Limited (LBT:ASX) has a franking level of 0%.
LBT Innovations Limited (LBT:ASX) is classified in the Healthcare.
The current P/E ratio for LBT Innovations Limited (LBT:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.